MeSH D006961 - hyperparathyroidism
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Calcitriol | Calcitriol | 2001-10-12 | |||
| Paricalcitol | Paricalcitol | 2013-09-27 | ||||
| Lupin Research | Doxercalciferol | Doxercalciferol | 2018-11-01 | |||
| Sandoz | Doxercalciferol | Doxercalciferol | 2014-05-05 | |||
| Paricalcitol | Paricalcitol | 2011-07-27 | ||||
| AbbVie | Calcitriol | Calcijex | 1986-09-25 | |||
| Paricalcitol | Zemplar | 1998-04-17 | $379 M | Q3/12-Q3/13 | ||
| Sanofi | Doxercalciferol | Hectorol | 1999-06-09 | |||
| Aurobindo Pharma | Paricalcitol | Paricalcitol | 2016-01-14 | |||
| Dr Reddys Laboratories | Paricalcitol | Paricalcitol | 2014-06-24 | |||
| Rising Pharmaceuticals | Doxercalciferol | Doxercalciferol | 2016-09-09 | |||
| Paricalcitol | Paricalcitol | 2014-06-24 | ||||
| Calcitriol | Calcitriol | 2018-11-21 | ||||
| Sun Pharmaceutical Industries | Calcitriol | Calcitriol | 2019-02-21 | |||
| Doxercalciferol | Doxercalciferol | 2019-11-14 | ||||
| Marksans Pharma | Paricalcitol | Paricalcitol | 2016-10-07 |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
80%4/5
Phase 2
0%0/4
Phase 3
86%6/7
Approved: 4Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use